Integrin alpha V polymorphisms and haplotypes in a Korean population are associated with susceptibility to chronic hepatitis and hepatocellular carcinoma

Liver International

Volumn 29, Issue 2, 2009, Pages 187-195

  Lee, Seung Ku ^a   Kim, Min Ho ^a   Cheong, Jae Youn ^b   Cho, Sung Won ^b   Yang, Song Ju ^c   Kwack, Kyu Bum ^a  

^a CHA University   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c Macrogen Inc   (South Korea)

Author keywords

Hepatitis B virus; Hepatocellular carcinoma; Integrinalpha V; Korean; Polymorphisms

Indexed keywords

ADENOSINE; CD51 ANTIGEN; CYTOSINE; GUANINE; THYMINE;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HEREDITY; HUMAN; INTRON; KOREA; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POPULATION RESEARCH; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HEPATITIS B, CHRONIC; HUMANS; INTEGRIN ALPHAV; KOREA; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; MIDDLE AGED; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 58149520589     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01843.x     Document Type: Article

References (48)

1. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006; 45: 529-38.
2. Arbuthnot P, Kew M. Hepatitis B virus and hepatocellular carcinoma. Int J Exp Pathol 2001; 82: 77-100.
3. Syvanen AC. Accessing genetic variation: Genotyping single nucleotide polymorphisms. Nat Rev Genet 2001; 2: 930-42.
4. Huang JL, Gao PS, Mathias RA, et al. Sequence variants of the gene encoding chemoattractant receptor expressed on Th2 cells (CRTH2) are associated with asthma and differentially influence mRNA stability. Hum Mol Genet 2004; 13: 2691-7.
5. Carter AM, Sachchithananthan M, Stasinopoulos S, Maurer F, Medcalf RL. Prothrombin G20210A is a bifunctional gene polymorphism. Thromb Haemost 2002; 87: 846-53.
6. Gehring NH, Frede U, Neu-Yilik G, et al. Increased efficiency of mRNA 3′ end formation: A new genetic mechanism contributing to hereditary thrombophilia. Nat Genet 2001; 28: 389-92.
7. Yu MW, Chang HC, Liaw YF, et al. Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. J Natl Cancer Inst 2000; 92: 1159-64.
8. Kim YJ, Lee HS, Im JP, et al. Association of transforming growth factor-beta1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Exp Mol Med 2003; 35: 196-202.
9. Kim YJ, Yoon JH, Kim CY, et al. IGF2 polymorphisms are associated with hepatitis B virus clearance and hepatocellular carcinoma. Biochem Biophys Res Commun 2006; 346: 38-44.
10. Shin HD, Park BL, Cheong HS, Yoon JH, Kim YJ, Lee HS. SPP1 polymorphisms associated with HBV clearance and HCC occurrence. Int J Epidemiol 2007; 36: 1001-8.
11. Tucker GC. Inhibitors of integrins. Curr Opin Pharmacol 2002; 2: 394-402.
12. Cooper CR, Chay CH, Pienta KJ. The role of alpha(v)beta(3) in prostate cancer progression. Neoplasia 2002; 4: 191-4.
13. Song G, Luo Q, Qin J, Wang B, Cai S. Expression of integrin beta1 and its roles on adhesion between different cell cycle hepatocellular carcinoma cells (SMMC-7721) and human umbilical vein endothelial cells. Colloids Surf B Biointerfaces 2004; 34: 247-52.
14. Carloni V, Mazzocca A, Pantaleo P, Cordella C, Laffi G, Gentilini P. The integrin, alpha6beta1, is necessary for the matrix-dependent activation of FAK and MAP kinase and the migration of human hepatocarcinoma cells. Hepatology 2001; 34: 42-9.
15. Rolli M, Fransvea E, Pilch J, Saven A, Felding-Habermann B. Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc Natl Acad Sci U S A 2003; 100: 9482-7.
16. Giannelli G, Fransvea E, Marinosci F, et al. Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin. Am J Pathol 2002; 161: 183-93.
17. Tsuchiya Y, Sawada S, Tsukada K, Saiki I. A new pseudo-peptide of Arg-Gly-Asp (RGD) inhibits intrahepatic metastasis of orthotopically implanted murine hepatocellular carcinoma. Int J Oncol 2002; 20: 319-24.
18. Cui R, Takahashi F, Ohashi R, et al. Abrogation of the interaction between osteopontin and alphavbeta3 integrin reduces tumor growth of human lung cancer cells in mice. Lung Cancer 2007; 57: 302-10.
19. Mettouchi A, Meneguzzi G. Distinct roles of beta1 integrins during angiogenesis. Eur J Cell Biol 2006; 85: 243-7.
20. Zhang H, Ozaki I, Mizuta T, et al. Beta 1-integrin protects hepatoma cells from chemotherapy induced apoptosis via a mitogen-activated protein kinase dependent pathway. Cancer 2002; 95: 896-906.
21. Carloni V, Romanelli RG, Pinzani M, Laffi G, Gentilini P. Expression and function of integrin receptors for collagen and laminin in cultured human hepatic stellate cells. Gastroenterology 1996; 110: 1127-36.
22. Bain VG, Ma M. Chronic hepatitis. In: Thomson ABR, Shaffer EA, eds. First Principles of Gastroenterology -the Basis of Disease and an Approach to Management, 3rd edn. Canada: AstraZeneca, 2005. Available from http://www.gastroresource.com/en/default.htm
23. Bruck R, Hershkoviz R, Lider O, Shirin H, Aeed H, Halpern Z. The use of synthetic analogues of Arg-Gly-Asp (RGD) and soluble receptor of tumor necrosis factor to prevent acute and chronic experimental liver injury. Yale J Biol Med 1997; 70: 391-402.
24. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996; 4: 25-36.
25. Sprengers D, Van Der Molen RG, Kusters JG, et al. Analysis of intrahepatic HBV-specific cytotoxic T-cells during and after acute HBV infection in humans. J Hepatol 2006; 45: 182-9.
26. Iwamoto H, Sakai H, Nawata H. Inhibition of integrin signaling with Arg-Gly-Asp motifs in rat hepatic stellate cells. J Hepatol 1998; 29: 752-9.
27. Nejjari M, Hafdi Z, Gouysse G, et al. Expression, regulation, and function of alpha V integrins in hepatocellular carcinoma: An in vivo and in vitro study. Hepatology 2002; 36: 418-26.
28. Patriarca C, Roncalli M, Viale G, et al. Extracellular matrix proteins, integrin receptors (VLA-beta 1, VLA-alpha 2 and VLA-alpha 5) and growth fraction in atypical macroregenerative nodules of the liver: An immunocytochemical case study. Histochemistry 1994; 102: 29-36.
29. Volpes R, Van Den Oord JJ, Desmet VJ. Integrins as differential cell lineage markers of primary liver tumors. Am J Pathol 1993; 142: 1483-92.
30. Liu LX, Jiang HC, Liu ZH, et al. Integrin gene expression profiles of human hepatocellular carcinoma. World J Gastroenterol 2002; 8: 631-7.
31. Katabami K, Mizuno H, Sano R, et al. Transforming growth factor-beta1 upregulates transcription of alpha3 integrin gene in hepatocellular carcinoma cells via Ets-transcription factor-binding motif in the promoter region. Clin Exp Metastasis 2005; 22: 539-48.
32. Felding-Habermann B, Habermann R, Saldivar E, Ruggeri ZM. Role of beta3 integrins in melanoma cell adhesion to activated platelets under flow. J Biol Chem 1996; 271: 5892-900.
33. Pilch J, Habermann R, Felding-Habermann B. Unique ability of integrin alpha(v)beta 3 to support tumor cell arrest under dynamic flow conditions. J Biol Chem 2002; 277: 21930-8.
34. Ramos DM, But M, Regezi J, et al. Expression of integrin beta 6 enhances invasive behavior in oral squamous cell carcinoma. Matrix Biol 2002; 21: 297-307.
35. Yao M, Zhou XD, Zha XL, et al. Expression of the integrin alpha5 subunit and its mediated cell adhesion in hepatocellular carcinoma. J Cancer Res Clin Oncol 1997; 123: 435-40.
36. Grigorescu M. Noninvasive biochemical markers of liver fibrosis. J Gastrointestin Liver Dis 2006; 15: 149-59.
37. Li J, Tan H, Dong X, et al. Antisense integrin alphaV and beta3 gene therapy suppresses subcutaneously implanted hepatocellular carcinomas. Dig Liver Dis 2007; 39: 557-65.
38. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-30.
39. Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal human monocytes: Inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995; 99: 303-10.
40. Tsukamoto H. Cytokine regulation of hepatic stellate cells in liver fibrosis. Alcohol Clin Exp Res 1999; 23: 911-6.
41. Bataller R, North KE, Brenner DA. Genetic polymorphisms and the progression of liver fibrosis: A critical appraisal. Hepatology 2003; 37: 493-503.
42. Morley M, Molony CM, Weber TM, et al. Genetic analysis of genome-wide variation in human gene expression. Nature 2004; 430: 743-7.
43. Sims MA, Field SD, Barnes MR, et al. Cloning and characterisation of ITGAV, the genomic sequence for human cell adhesion protein (vitronectin) receptor alpha subunit, CD51. Cytogenet Cell Genet 2000; 89: 268-71.
44. Donahue JP, Sugg N, Hawiger J. The integrin alpha v gene: Identification and characterization of the promoter region. Biochim Biophys Acta 1994; 1219: 228-32.
45. Ueda H, Howson JM, Esposito L, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423: 506-11.
46. Day DA, Tuite MF. Post-transcriptional gene regulatory mechanisms in eukaryotes: An overview. J Endocrinol 1998; 157: 361-71.
47. Elliott L, Ashley-Koch AE, De Castro L, et al. Genetic polymorphisms associated with priapism in sickle cell disease. Br J Haematol 2007; 137: 262-7.
48. Jacq L, Garnier S, Dieude P, et al. The ITGAV rs3738919-C allele is associated with rheumatoid arthritis in the European Caucasian population: A family-based study. Arthritis Res Ther 2007; 9: R63.